Takeda commits $30+ M in 5 new global CSR partnerships

Japanese pharmaceutical firm Takeda has announced five new partnerships to its Global Corporate Social Responsibility (CSR) Programme, which contribute to strengthening health systems in low- and middle-income countries. The new partnerships bring its total contributions to JPY 24.2 billion (Approx. $167.5 million) across 29 long-term partnerships. Takeda expects that Global CSR Programme’s new five partnerships will bring its reach to 25.2 million people in 92 countries by 2028. Takeda’s commitments to these new partners in FY2023 include JPY 834 million (Approx. $5.8 million) to Society for Family Health, Rwanda to expand access to quality healthcare in remote and hard-to-reach communities; JPY 1,146 million (Approx. $7.9 million) to Relief International to improve access to essential medicines and medical supplies in Afghanistan, Yemen, Myanmar and Syria; JPY 1,048 million (Approx. $7.3 million) to Mercy Corps to help climate-fragile communities through the addition of Resilience Hubs in Jamaica, US Virgin Islands, St. Kitts and Nevis, and St. Lucia, as part of their Caribbean Resilience Initiative; JPY 671 million (Approx. $4.6 million) to Partners In Health to elevate and equip 3,000 nurses and midwives in Haiti, Mexico, Peru, Lesotho, Liberia, Malawi, Rwanda and Sierra Leone; and JPY 793 million (Approx. $5.5 million) to the University of Nairobi to create a pioneering, public health-focused machine learning and data science training programme to strengthen the leadership pipeline and impact of women to improve health in their communities.